Danish pharmaceutical multinational Novo Nordisk is expanding its presence in inherited blood disorder treatments ...
At the San Antonio Breast Cancer Symposium, investigators reported phase III results showing that the oral selective estrogen ...
Many doctors agree with the Food and Drug Administration’s recent decision to remove the black box warnings on at least some ...
Tukysa, combined with Herceptin and Perjeta, extends progression-free survival in HER2+ metastatic breast cancer, showing ...
Get the live share price of Viking Therapeutics Inc (VKTX), including intraday charts, historical performance, key financials, and market updates. Track the latest US stock market activity.
In an international study led by UCLA, researchers have shown that giredestrant, a next-generation oral selective estrogen ...
A study led by biomedical scientists at the University of California, Riverside, has shown for the first time that a father's ...
MedPage Today on MSN
Overcoming CDK4/6 Inhibitor Resistance in HR-Positive/HER2-Negative Breast Cancer
In the CAPItello-291 trial of capivasertib plus fulvestrant, 73% of patients had already received a CDK4/6 inhibitor. As ...
News-Medical.Net on MSN
Paternal microplastic exposure alters metabolic health in offspring
A study led by biomedical scientists at the University of California, Riverside, has shown for the first time that a father's ...
Summary Affected products Unauthorized seized health products, including: Issue Health Canada is warning consumers about multiple unauthorized drug products seized ...
The gut–islets axis connects nutrient sensing in the intestine with insulin secretion from the pancreas and plays an essential role in glucose regulation. GLP-1 released by intestinal L cells can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results